New Hampshire Hematology Oncology
200 Technology Drive
Hooksett, New Hampshire 03106
Hooksett, New Hampshire 03106
We've found
1 trials
at this facility
Triple Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
